1 / 12

Amatoxin

Gene transcription is a process that transfers the genetic information into carriers such as mRNA and guides subsequent cellular metabolic activities. Interruption of gene transcription will result in catastrophic impacts and lead to cell death.

AveryLee
Download Presentation

Amatoxin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Amatoxins https://www.creative-biolabs.com/adc

  2. Amatoxins • Gene transcription is a process that transfers the genetic information into carriers such as mRNA and guides subsequent cellular metabolic activities. Interruption of gene transcription will result in catastrophic impacts and lead to cell death. Many of the transcription inhibitors have decent pharmacological effects against tumor growth and a number of anti-cancer drugs have been identified or developed to restrain transcription, among which amatoxins have been shown to exhibit high tumor inhibition potency

  3. Amatoxins are a group of toxic compounds commonly produced by green and white Amanita muscaria and result in fatal human Amanita intoxications upon ingestion. They are synthesized via the cleavage, modification, and cyclization of precursor peptides that usually contain a ~10 amino acid-residue leader peptide followed by the amatoxin peptide and a recognition sequence. • The recognition sequence starts with a conserved Cys residue and has several conserved peptide motifs including the DDV motif and the LLTRGE motif. Chemically, amatoxins are cyclic octapeptides with a basic peptide sequence template: Ile-Trp-Gly-Ile-Gly-Cys-Asn-Pro. • This octapeptide is cyclized by the peptide bond between Ile and Pro residues and it is also featured by an internal cross-bridge formed by the Cys and Trp residues.

  4. LOREM IPSUM Lorem ipsum dolor sit amet, consecteturadipisicingelit, sed do eiusmodtemporincididuntutlabore et dolore magna aliqua.

  5. LOREM IPSUM DOLOR Cyclic octapeptide structure of amatoxin and its variants. Amatoxins are chemically versatile with different modifications on the “R” groups generate at least 9 variants.

  6. Content A Amatoxins Mode of Action (MOA) B Amatoxins Mode of Action (MOA)

  7. A Amatoxins Mode of Action (MOA) Amatoxins are powerful inhibitors of gene transcription and preferentially target RNA polymerase II, a crucial enzyme in mRNA biosynthesis. RNA polymerase II complex contains a conserved 35-amino-acid-long bridge helix that is important for the DNA translocation. α-amanitin, the major form of amatoxin, has been demonstrated to bind the free RNA polymerase II core adjacent to the bridge helix and thus interfere with its movement and lead to the diminishing of DNA translocation during mRNA synthesis.

  8. α-amanitin bound to RNA polymerase II at the bridge helix region and stabilizes the RNA polymerase II elongation complex to prevent DNA translocation and mRNA elongation (PNAS, 2002).

  9. A Amatoxins-based ADCs Amatoxins, especially α-amanitin, are promising toxic payloads in ADC developments based on their specific MOA and high water solubility. Recently, α-amanitin based ADCs are under active development and evaluation, while some have exhibited decent efficacy in drug resistant tumor lines, for example, tumor-initiating cells and tumor cells expressing multi-drug resistant transporters. In one case, α-amanitin is conjugated to an anti-EpCAM antibody and the resulted ADC has shown good efficacy against pancreatic carcinomas and some other EpCAM-expressing malignancies.

  10. Structure of chiHEA125-Ama ADC. This ADC is constructed by conjugating α-amanitin to an anti-EpCAM antibody (chiHEA125) via a non-cleavable Glutarate linker (left) and it showed similar binding pattern towards the target antigen as non-conjugated chiHEA125 antibody (right) (JNCI, 2012).

  11. Contact us 45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-619-7922 Fax: 1-631-207-8356 Email: marketing@creative-biolabs.com

  12. THANKS

More Related